Financhill
Sell
26

BDRX Quote, Financials, Valuation and Earnings

Last price:
$3.93
Seasonality move :
-9.68%
Day range:
$3.90 - $4.22
52-week range:
$3.50 - $74.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.52x
P/B ratio:
0.21x
Volume:
21.3K
Avg. volume:
263.7K
1-year change:
-94%
Market cap:
$2.3M
Revenue:
$474.1K
EPS (TTM):
-$74.60

Earnings Data

Next earnings date for BDRX
Apr 18
2025
Most recent earnings per share
--
Missed by --
(Dec 31/2018)
Consensus Estimate
--
(Dec 31/2018)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

BDRX Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
06/30/2019 Q2 -- -- -- -$208.17 --
03/31/2019 Q1 -- -- -- -$104.09 --
12/31/2018 Q4 -- -- -- -- --
09/30/2018 Q3 -- -- -- -$5,107.44 --
06/30/2018 Q2 -- -- -- -- --
03/31/2018 Q1 -- -- -- -$7,794.30 --
12/31/2017 Q4 -- -- -- -- --
09/30/2017 Q3 -- -- -- -$6,395.04 --
06/30/2017 Q2 -- -- -- -- --
12/31/2016 Q4 -- -- -- -- --
06/30/2016 Q2 -- -- -- -- --
12/31/2015 Q4 -- -- -- -- --

Biodexa Pharmaceuticals PLC Earnings Questions

  • How Much did Biodexa Pharmaceuticals PLC Generate in Revenue Last Quarter?

    Biodexa Pharmaceuticals PLC reported -- worth of top line sales in its most recent quarter.

  • Did Biodexa Pharmaceuticals PLC Beat Earnings Last Quarter?

    Biodexa Pharmaceuticals PLC announced earnings per share of -- which represents a miss of analyst forecast a -- per share.

  • Is Biodexa Pharmaceuticals PLC Profitable?

    Biodexa Pharmaceuticals PLC reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Biodexa Pharmaceuticals PLC EPS Next Year?

    Biodexa Pharmaceuticals PLC's earnings are forecast to decrease from -$248.86 per share to -$0.24 per share next year representing a decrease of -99.94%.

  • When is Biodexa Pharmaceuticals PLC's Earnings Date?

    Biodexa Pharmaceuticals PLC's next earnings date is April 18, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock